Roche Pharma R&D (pRED)

Our scientists are amongst the best in the industry, discovering and translating cutting-edge science in the pursuit of delivering life-changing benefits to patients.

We continue to be driven by our long-term aim to deliver these medical advances that provide greater benefits to patients, and at the same time, reduce the healthcare burden on society.

pRED's research spans across 6 disease areas: Oncology , Neuroscience , Immunology and Infectious diseases , Ophthalmology and Rare diseases .

pRED scientists pursue excellence. Patients are waiting, so by pushing boundaries pRED scientists make breakthroughs every day. Found out some examples of areas where pRED is leading the field.

Excellence in science

See all stories

Revolutionary discoveries in science are truly enabled when we have open minds and ears to share and collaborate.
Hans Clevers
Head of pRED, Roche

At pRED, it’s not the easy questions that excite us, it’s the biggest challenges in healthcare. That’s why we’ve set ourselves big goals to discover treatments that provide greater benefits for patients at a lower cost to society. This means having the expertise, resources and latest technologies at our fingertips, within an organisation that nurtures innovation built on curiosity and responsibility.

Meet Gijs van den Brink, Global Head of Immunology, Infectious Diseases and Ophthalmology, Roche pRED
Meet Madhu Benakareddy, Research Project Leader, Roche pRED
Meet Sascha Fauser, Global Head of Ophthalmology, Roche pRED
Meet the Roche pRED Cancer Immunotherapy Team
Meet the Roche pRED Cancer Immunotherapy Team
Meet the Roche pRED Molecular Targeted Therapy Team
Meet a few members of the Roche pRED Oncology Team

Meet the pRED scientists

See all stories

More from the Roche Group

Get to know our structure

Discover more